Log In
Print this Print this

H103 (AD-HE)

  Manage Alerts
Collapse Summary General Information
Company Shanghai Sunway Biotech Co. Ltd.
DescriptionModified adenovirus with deletion of an E1B-55kd segment and insertion of heat shock protein 70 (Hsp70) into H101 backbone
Molecular Target
Mechanism of ActionOncolytic virus
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I
Standard IndicationHead and neck cancer
Indication DetailsTreat head and neck cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today